Many GLP-1 peptides and their impurities are moderately to strongly metal-sensitive, resulting in non-specific adsorption (NSA) to surfaces containing metals, such as stainless-steel (SST) surfaces
In preclinical models, chronic GLP-1 administration improves depression-like behaviors even in lean animals, an effect not mediated by weight loss
By focusing on a nutrient-rich diet, staying hydrated and listening to your body, you can navigate symptoms like nausea, fatigue and constipation effectively
Phentermine carries risks related to the heart and blood pressure, while semaglutide carries risks related to the gastrointestinal tract and thyroid
It stimulates the release of insulin in response to elevated blood glucose and suppresses the release of glucagon, a hormone that raises blood sugar levels
In patients with CKD who are at increased risk for cardiovascular events, use of a GLP-1 RA may reduce the risk of progression of albuminuria, cardiovascular events, or both